Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -2024202320222021202020192018201720162015 13 July 2016 Disclosure of a Transparency Notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Regulated information 21 June 2016 Biocartis launches advanced EGFR Mutation Assay detecting over 50 mutations Important addition to Biocartis’ core oncology menu now covering most known and used oncology biomarkers Non-regulated information 1 June 2016 Idylla™ Ebola Virus Triage Test Granted Emergency Use Authorization by U.S. FDA Non-regulated information 23 May 2016 Study demonstrating Biocartis’ BRAF liquid biopsy assay... Test can predict therapy response over the course of the cancer treatment Non-regulated information 13 May 2016 Results of the Annual General Meeting held on 13 May 2016 Regulated information 12 May 2016 Biocartis Q1 2016 Business Update Regulated information 26 April 2016 Biocartis Strengthens Biomarker Portfolio for Colorectal Cancer Exclusive license of recently detected EGFR resistance mutations Non-regulated information 12 April 2016 Biocartis Announces Publication of 2015 Annual Report and Invitation to Annual General Meeting Regulated information 11 April 2016 Disclosure of Outstanding Voting Securities Regulated information 17 March 2016 Biocartis Announces 2015 Results and 2016 Guidance Regulated information Pagination First page « First Previous page ‹‹ … Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Current page 29 Page 30 Page 31 Next page ›› Last page Last »